Vireo Growth (VREOF) Cash from Operations (2020 - 2026)
Vireo Growth's (VREOF) quarterly Cash from Operations came in at 11900000.0 in Q1 2026, up 450.0% year-on-year from 2163636.36 in Q1 2025, and down 36.21% quarter-over-quarter from 18655743.0 in Q4 2025.
Vireo Growth (VREOF) Cash from Operations (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Cash from Operations across 7 years of filings, most recently posting 11900000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 11900000.0, up 450.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19011491.0 (up 252.77% YoY), and the FY2025 annual result was 3711491.0, up 136.26% from the prior year.
- Cash from Operations came in at 11900000.0 for Q1 2026 at Vireo Growth, down from 18655743.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 18655743.0 in Q4 2025 to a low of 6792823.0 in Q3 2025.
- The 5-year median for Cash from Operations is 2591374.0 (2024), against an average of 803660.59.
- Across the five-year window, Cash from Operations slumped 49694.9% in 2025 and soared 450.0% in 2026, its largest moves.
- Vireo Growth's Cash from Operations stood at 6119043.0 in 2022, then surged by 92.49% to 459544.0 in 2023, then plunged by 1302.11% to 6443302.0 in 2024, then soared by 389.54% to 18655743.0 in 2025, then plunged by 36.21% to 11900000.0 in 2026.
- The last three Cash from Operations figures came in at 11900000.0 (Q1 2026), 18655743.0 (Q4 2025), and 6792823.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 11.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.90 Mn |
| Mar 31, 2026 | 11.90 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Mar 31, 2025 | -3.40 Mn |
| Dec 31, 2024 | -6.44 Mn |
| Dec 31, 2024 | -6.44 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Jun 30, 2024 | -9,542.00 |
| Jun 30, 2024 | -9,542.00 |
| Mar 31, 2024 | -1.19 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | -459,544.00 |
| Dec 31, 2023 | -459,544.00 |